Carmot Therapeutics Closes $160 Million Series D Financing to Advance Clinical Pipeline of Novel Incretin Receptor Modulators Portfolio News / By Karina Tin July 26, 2022 Carmot Therapeutics Closes $160 Million Series D Financing to Advance Clinical Pipeline of Novel Incretin Receptor Modulators Read More »
Circle Pharma Appoints Paul Park MBA as CBO Portfolio News / By Karina Tin July 26, 2022 Circle Pharma Appoints Paul Park MBA as CBO Read More »
Kallyope and Brightseed Enter Collaboration to Identify and Validate Novel Plant-Based Bioactives Portfolio News / By Karina Tin July 21, 2022 Kallyope and Brightseed Enter Collaboration to Identify and Validate Novel Plant-Based Bioactives Read More »
Nurix Therapeutics Announces $40 Million Registered Direct Offering Portfolio News / By Karina Tin July 8, 2022 Nurix Therapeutics Announces $40 Million Registered Direct Offering Read More »
Nurix Therapeutics Announces $55 Million Registered Direct Offering Portfolio News / By Karina Tin July 7, 2022 Nurix Therapeutics Announces $55 Million Registered Direct Offering Read More »
Nurix Therapeutics Reports Fiscal Second Quarter 2022 Financial Results and Provides a Corporate Update Portfolio News / By Karina Tin July 7, 2022 Nurix Therapeutics Reports Fiscal Second Quarter 2022 Financial Results and Provides a Corporate Update Read More »
Kallyope, Pioneers in Drug Discovery via the Gut-Brain Axis, Advances Discovery and Development Teams With New Appointments Portfolio News / By Karina Tin July 6, 2022 Kallyope, Pioneers in Drug Discovery via the Gut-Brain Axis, Advances Discovery and Development Teams With New Appointments Read More »
Tenaya Therapeutics Publishes Preclinical Data in Science Translational Medicine Detailing Discovery of HDAC6 Inhibitor for Treatment of Heart Failure Portfolio News / By Karina Tin July 6, 2022 Tenaya Therapeutics Publishes Preclinical Data in Science Translational Medicine Detailing Discovery of HDAC6 Inhibitor for Treatment of Heart Failure Read More »
